logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
Showing 1 - 20 of 279 Items
Showing 1 - 20 of 279 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Research

Reaching the “last mile”: describing community clinics implemented to increase COVID-19 vaccine uptake in Peel region, Canada

So J, Nicholson-Baker D, Rahman S, Ramuscak N, Reid A,  et al.
2025-05-27 • BMC Public Health
2025-05-27 • BMC Public Health

BACKGROUND

COVID-19 hit Canada hard and exacerbated health inequities, notably among ethnoracially minoritized populations. By August 2021, some areas in Peel r...

Journal Article
|
Research

Mental health and COVID-19 vaccine hesitancy among health-related university students: a cross-sectional multi-center study

Khongyot T, Takyi A, Ndzeshang DS, Fai KGN, Win TZ,  et al.
2025-05-19 • Tropical Medicine and Health
2025-05-19 • Tropical Medicine and Health

BACKGROUND

The mental health problems during the coronavirus disease 2019 (COVID-19) pandemic may have influenced their decision to receive the COVID-19 vaccine...

Journal Article
|
Research

Using an analogue-digital hybrid clinical data management platform during a two-dose preventive Ebola virus vaccine trial in Goma, the Democratic Republic of the Congo

Brindle HE, Tetsa-Tata D, Edwards T, Choi EML, Kasonia K,  et al.
2025-05-02 • PLOS Global Public Health
2025-05-02 • PLOS Global Public Health

Clinical trials in settings with intermittent or non-existent internet and power connectivity, for example ...

Journal Article
|
Letter

DR Congo's conflict and cholera: a call for ring vaccination

Al-Rabeeah AA, Ebrahim SH, Mwamba D, Ditekemena J, Christou C,  et al.
2025-04-04 • Lancet Infectious Diseases
2025-04-04 • Lancet Infectious Diseases
Journal Article
|
Research

High confidence and demand for hepatitis E vaccine during an outbreak in Bentiu, South Sudan: A qualitative study

Koyuncu A, Asilaza KV, Rumunu J, Wamala J, Gitahi P,  et al.
2025-03-06 • PLOS Global Public Health
2025-03-06 • PLOS Global Public Health

In 2021 in response to an outbreak of hepatitis E in Bentiu internally displaced persons camp the South Sudanese Ministry of Health with support from Médecins Sans Frontières implemen...

Journal Article
|
Research

Low-dose yellow fever vaccine in adults in Africa

Kimathi D, Juan-Giner A, Bob NS, Orindi B, Namulwana ML,  et al.
2025-02-20 • New England Journal of Medicine
2025-02-20 • New England Journal of Medicine

BACKGROUND

Yellow fever vaccine is highly effective with a single dose, but vaccine supply is limited. The minimum dose requirements for seroconversion remain u...

Journal Article
|
Research

The effectiveness of two doses of recombinant hepatitis E vaccine in response to an outbreak in Bentiu, South Sudan: a case–control and bias indicator study

Nesbitt RC, Kinya Asilaza V, Alvarez C, Gitahi P, Nkemenang P,  et al.
2025-01-08 • Lancet Infectious Diseases
2025-01-08 • Lancet Infectious Diseases

BACKGROUND

Hepatitis E virus (HEV) is a leading cause of acute viral hepatitis, particularly in Asia and Africa, where HEV genotypes 1 and 2 are prevalen...

Journal Article
|
Research

Effect of mass campaigns with full and fractional doses of pneumococcal conjugate vaccine (Pneumosil) on the reduction of nasopharyngeal pneumococcal carriage in Niger: a three-arm, open-label, cluster-randomised trial

Coldiron ME, Soumana I, Baudin E, Langendorf C, Mamiafo Tchoula C,  et al.
2025-01-08 • Lancet Infectious Diseases
2025-01-08 • Lancet Infectious Diseases

BACKGROUND

In settings with low pneumococcal conjugate vaccine (PCV) coverage, multi-age cohort mass campaigns could increase population immunity, and fractiona...

Journal Article
|
Research

Effectiveness of the primary Bacillus Calmette-Guérin vaccine against the risk of Mycobacterium tuberculosis infection and tuberculosis disease: a meta-analysis of individual participant data

Pelzer PT, Stuck L, Martinez L, Richards AS, Acuña-Villaorduña C,  et al.
2024-12-19 • Lancet Microbe
2024-12-19 • Lancet Microbe

BACKGROUND

Tuberculosis vaccine trials using disease as the primary endpoint are large, time consuming, and expensive. An earlier immunological measure of the p...

Journal Article
|
Research

Experiences and perceptions of migrant populations in South Africa on COVID-19 immunization: an interpretative phenomenological analysis

Mukumbang FC, Ndlovu S, Adebiyi BO
2024-11-12 • BMC Public Health
2024-11-12 • BMC Public Health

INTRODUCTION

Migrant populations (asylum seekers, permit holders, refugees, and undocumented migrants) living in South Africa face various individual, social, a...

Journal Article
|
Research

rVSV-ZEBOV vaccination in people with pre-existing immunity to Ebolavirus: an open-label safety and immunogenicity study in Guinean communities affected by Ebola virus disease (l’essai proches)

Watson CH, Gsell PS, Hall Y, Camacho A, Riveros X,  et al.
2024-11-07 • BMC Medicine
2024-11-07 • BMC Medicine

BACKGROUND

Zaire Ebolavirus disease (EVD) outbreaks can be controlled using rVSV-ZEBOV vaccination and other public health measures. People in high-risk areas m...

Journal Article
|
Research

Dynamic factors associated with COVID-19 vaccine uptake in Cameroon between 2021 and 2022

Tchiasso D, Mendjime P, Nana Wandji BS, Yuya F, Stanton AM,  et al.
2024-10-24 • Journal of Public Health In Africa
2024-10-24 • Journal of Public Health In Africa

BACKGROUND

Lit...

Journal Article
|
Research

Oral cholera vaccine coverage in Goma, Democratic Republic of the Congo, 2022, following 2019–2020 targeted preventative mass campaigns

Briskin E, Bateyi Mustafa SH, Mahamba R, Kabunga D, Kubuya J,  et al.
2024-10-01 • Vaccine X
2024-10-01 • Vaccine X

BACKGROUND

In 2019–2020, preventative Oral Cholera Vaccine campaigns were conducted in 24/32 n...

Journal Article
|
Case Report/Series

Effectiveness of rVSV-ZEBOV vaccination during the 2018–20 Ebola virus disease epidemic in the Democratic Republic of the Congo: a retrospective test-negative study

Meakin S, Nsio J, Camacho A, Kitenge R, Coulborn RM,  et al.
2024-08-01 • Lancet Infectious Diseases
2024-08-01 • Lancet Infectious Diseases

BACKRGOUND

The rec...

Journal Article
|
Research

Immunogenicity of an extended dose interval for the Ad26.ZEBOV, MVA-BN-Filo Ebola vaccine regimen in adults and children in the Democratic Republic of the Congo

Choi EM, Kasonia K, Kavunga-Membo H, Mukadi-Bamuleka D, Soumah A,  et al.
2024-07-26 • Vaccines
2024-07-26 • Vaccines

During the 2018–2020 Ebola virus disease outbreak in Democratic Republic of the Congo, a phase 3 trial of the Ad26.ZEBOV, MVA-BN-Filo Ebola vaccine (DRC-EB-001) commenced in Goma, wit...

Journal Article
|
Research

Delivery and safety of a two-dose preventive Ebola virus disease vaccine in pregnant and non-pregnant participants during an outbreak in the Democratic Republic of the Congo

Kavunga-Membo H, Watson-Jones D, Kasonia K, Edwards T, Camacho A,  et al.
2024-07-23 • Vaccines
2024-07-23 • Vaccines

During the 2018–2020 Ebola virus disease (EVD) outbreak, residents in Goma, Democratic Republic of the Congo, were offered a two-dose prophylactic EVD vaccine. This was the first stud...

Conference Material
|
Video

Determining whether mass vaccination campaigns with fractional dose of PCV10 (Pneumosil®) could accelerate herd protection against pneumococcal transmission in sub-Saharan Africa

Soumana I
2024-07-01 • Epicentre Scientific Day 2024
2024-07-01 • Epicentre Scientific Day 2024
Journal Article
|
Commentary

Accumulating evidence on the long-term immunogenicity of fractional dosing for yellow fever vaccines

Juan-Giner A, Warimwe GM
2024-06-01 • Lancet Infectious Diseases
2024-06-01 • Lancet Infectious Diseases
Conference Material
|
Abstract

Effectiveness of rVSV-ZEBOV vaccination during the 10th Ebola virus disease epidemic in the Democratic Republic of the Congo: a retrospective observational analysis

Meakin S
2024-05-23 • Epicentre Scientific Day 2024
2024-05-23 • Epicentre Scientific Day 2024
BACKGROUND
The recombinant vesicular stomatitis virus–Zaire Ebola virus (rVSV-ZEBOV) vaccine is the only vaccine recommended for use to respond to Zaire ebolavirus outbreaks by SAGE....
Conference Material
|
Poster

Impact of OCV preventative campaigns strategies for cholera elimination: A comprehensive research project in Democratic Republic of the Congo

Broban A, Meakin S, Mukadi D, Mahamba R, Roederer T,  et al.
2024-05-23 • Epicentre Scientific Day 2024
2024-05-23 • Epicentre Scientific Day 2024